NCT07405333 Effect of Coughing Exercises Versus Incentive Spirometry on Respiratory Function and Recovery in Children After Cardiac Surgery.
| NCT ID | NCT07405333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Baghdad |
| Condition | Congenital Heart Disease (CHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 99 participants |
| Start Date | 2025-12-07 |
| Primary Completion | 2026-08-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 99 participants in total. It began in 2025-12-07 with a primary completion date of 2026-08-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the effects of coughing exercises and incentive spirometry (IS) on lung function and recovery in children who undergo heart surgery. The main goals are to see: How coughing exercises and IS affect breathing and lung function after surgery? How these exercises influence overall recovery after surgery? Children who participate will be randomly assigned to one of three groups: coughing exercises, IS, or standard care. Those in the exercise groups will perform their assigned breathing exercises every 3 hours for the first 3 days after surgery. Daily check-ups will be conducted to monitor their progress, lung function, and oxygen levels. The study will measure breathing ability, oxygen levels, and recovery milestones to find out which method is most effective in preventing lung complications and helping children recover faster.
Eligibility Criteria
Inclusion Crit * Children aged 6 to 18 years scheduled for elective cardiac surgery. * Postoperative extubation within 24 hours and judged clinically stable to begin respiratory therapy. * Hemodynamically stable. Exclusion Criteria: * Pre-existing moderate-to-severe chronic lung disease requiring baseline oxygen therapy. * Neuromuscular disorders significantly impairing cough/inspiratory effort. * Emergency surgery, ongoing major bleeding. * Prolonged mechanical ventilation \>72 hours or tracheostomy on admission.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07405333 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Congenital Heart Disease (CHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07405333 currently recruiting?
Yes, NCT07405333 is actively recruiting participants. Contact the research team at rusal.khaled1606a@conursing.uobaghdad.edu.iq for enrollment information.
Where is the NCT07405333 trial being conducted?
This trial is being conducted at Baghdad, Iraq, Baghdad, Iraq, Baghdad, Iraq, Karbala, Iraq.
Who is sponsoring the NCT07405333 clinical trial?
NCT07405333 is sponsored by University of Baghdad. The trial plans to enroll 99 participants.